BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32245535)

  • 1. Novel Therapies in Hepatic Encephalopathy.
    Alimirah M; Sadiq O; Gordon SC
    Clin Liver Dis; 2020 May; 24(2):303-315. PubMed ID: 32245535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy.
    Alsahhar JS; Rahimi RS
    Curr Opin Gastroenterol; 2019 May; 35(3):145-154. PubMed ID: 30893082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic Management of Hepatic Encephalopathy.
    Mahpour NY; Pioppo-Phelan L; Reja M; Tawadros A; Rustgi VK
    Clin Liver Dis; 2020 May; 24(2):231-242. PubMed ID: 32245530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Overt Hepatic Encephalopathy.
    Sussman NL
    Clin Liver Dis; 2015 Aug; 19(3):551-63. PubMed ID: 26195208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Ammonia-Lowering Agents for Hepatic Encephalopathy.
    Rahimi RS; Rockey DC
    Clin Liver Dis; 2015 Aug; 19(3):539-49. PubMed ID: 26195207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
    Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic encephalopathy due to liver cirrhosis.
    Ellul MA; Gholkar SA; Cross TJ
    BMJ; 2015 Aug; 351():h4187. PubMed ID: 26265724
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatic encephalopathy--therapy].
    Wettstein M; Häussinger D
    Dtsch Med Wochenschr; 2003 Dec; 128(50):2658-60. PubMed ID: 14673743
    [No Abstract]   [Full Text] [Related]  

  • 9. Current and emerging strategies for treating hepatic encephalopathy.
    Foster KJ; Lin S; Turck CJ
    Crit Care Nurs Clin North Am; 2010 Sep; 22(3):341-50. PubMed ID: 20691385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia.
    Rahimi RS; Rockey DC
    Semin Liver Dis; 2016 Feb; 36(1):48-55. PubMed ID: 26870932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta-analysis involving 826 patients based on 10 randomized controlled trials.
    Cai XJ; Wang L; Hu CM
    J Cell Biochem; 2018 Nov; 119(10):8336-8345. PubMed ID: 29932239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic encephalopathy: a critical current review.
    Hadjihambi A; Arias N; Sheikh M; Jalan R
    Hepatol Int; 2018 Feb; 12(Suppl 1):135-147. PubMed ID: 28770516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hyperammonemia in liver failure.
    Jover-Cobos M; Khetan V; Jalan R
    Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):105-10. PubMed ID: 24281376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention and treatment of hepatic encephalopathy].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):144-147. PubMed ID: 29171503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic Management of Hepatic Encephalopathy.
    Khalessi A; Pyrsopoulos NT
    Clin Liver Dis; 2024 May; 28(2):287-296. PubMed ID: 38548440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update on the management of hepatic encephalopathy].
    García Martínez R; Córdoba Cardona J
    Rev Esp Enferm Dig; 2008 Oct; 100(10):637-44. PubMed ID: 19119790
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonpharmacologic Management of Hepatic Encephalopathy: An Update.
    Weir V; Reddy KR
    Clin Liver Dis; 2020 May; 24(2):243-261. PubMed ID: 32245531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurology and the liver.
    Jones EA; Weissenborn K
    J Neurol Neurosurg Psychiatry; 1997 Sep; 63(3):279-93. PubMed ID: 9328238
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV; Sharma BC; Sharma P; Sarin SK
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newer aspects of hepatic encephalopathy.
    Mullen KD
    Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S17-20. PubMed ID: 15025247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.